Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma

NCT00522782 is registered in ClinicalTrials.gov with AAADRS Clinical Research Center as lead sponsor.

NCT NCT00522782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00522782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma
Lead sponsor
AAADRS Clinical Research Center
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2007
Completion date
January 31, 2009
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma